Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis.

Neurologia i neurochirurgia polska - 1 Jan 2023

Rzepiński Łukasz, Kośliński Piotr, Kowalewski Mariusz, Koba Marcin, Maciejek Zdzisław

Abstract excerpt

AIM OF THE STUDY: Amino acid metabolism is crucial for regulating immune responses and can be monitored in blood serum samples. This study aimed to analyse serum amino acid profiles in people with multiple sclerosis (pwMS), taking into account differences depending on the disease outcomes. CLINICAL RATIONALE FOR THE STUDY: Serum amino acid profiling is a promising, reproducible and minimally invasive technology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acids
Share to Biomarkers
Share to Multiple Sclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis, Chronic Progressive

Share to Multiple Sclerosis, Relapsing-Remitting

Share to Phenotype

Source

Identifiers

PMID: 37526173
DOI: 10.5603/PJNNS.a2023.0054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis.PMID 37526173Read ↗

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosisSemantic proximity Read ↗

Cerebrospinal fluid lipidomic biomarker signatures of demyelination for multiple sclerosis and Guillain–Barré syndromeSemantic proximity Read ↗

Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.Semantic proximity Read ↗

Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum.Semantic proximity Read ↗

MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progressionSemantic proximity Read ↗

CSF Proteomics Identifies Specific and Shared Pathways for Multiple Sclerosis Clinical SubtypesSemantic proximity Read ↗

Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosisSemantic proximity Read ↗

Chiral shift toward D-serine reflects intrathecal inflammation in multiple sclerosis and counteracts motor impairment in a murine modelSemantic proximity Read ↗

Quantitative proteomics and multi-omics analysis identifies potential biomarkers and the underlying pathological molecular networks in Chinese patients with multiple sclerosisSemantic proximity Read ↗

Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.Semantic proximity Read ↗

Exploring proteomic immunoprofiles: common neurological and immunological pathways in multiple sclerosis and type 1 diabetes mellitusSemantic proximity Read ↗

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.